Surgical treatment of nasopharyngeal carcinoma

Abstract

Nasopharyngeal carcinoma (NPC) is a relatively rare cancer, primarily prevalent in China and other parts of Asia. Radiotherapy is the preferred treatment for primary NPC and has proven to be highly effective. However, approximately 10% of patients experience recurrence after treatment. Surgical intervention serves as a key treatment option for locally recurrent NPC and selected primary cases, aiming to completely remove the tumor while preserving normal tissues and functions as much as possible. This review provides a comprehensive overview of surgical treatment options for NPC discussing the advantages, disadvantages, appropriate indications, and outcomes of various surgical techniques, thus offering guidance for selecting the most suitable treatment approaches.

Keywords

Nasopharyngeal carcinoma / surgery / nasopharyngectomy

References

[1] Bray F,Soerjomataram I,Torre LA.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2018;68:394-424

[2] Chen YP,Le QT,Sun Y.Nasopharyngeal carcinoma.Lancet2019;394:64-80

[3] Yu WM.Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review.J Laryngol Otol2009;123:1067-74

[4] Tang LL,Chen CB.The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.Cancer Commun2021;41:1195-227 PMCID:PMC8626602

[5] Bossi P, Chan AT, Licitra L, et al; ESMO Guidelines Committee. Electronic address: [e-mail], EURACAN. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2021;32:452-65.

[6] Mao YP,Chen L.Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.Chin J Cancer2016;35:103 PMCID:PMC5192583

[7] Yi JL,Huang X.Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution.Int J Radiat Oncol Biol Phys2006;65:161-8

[8] Lee AWM,Chan JYW.Management of locally recurrent nasopharyngeal carcinoma.Cancer Treat Rev2019;79:101890

[9] Liu TR,Zhang GP.Different therapeutic strategies in primary salivary gland-type nasopharyngeal carcinomas.Curr Opin Otolaryngol Head Neck Surg2011;19:87-91

[10] Liu YP,Zou X.Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.Cancer Commun2019;39:75 PMCID:PMC6858734

[11] Badoual C.Update from the 5th edition of the World Health Organization classification of head and neck tumors: oropharynx and nasopharynx.Head Neck Pathol2022;16:19-30 PMCID:PMC9019010

[12] Wang HY,To KF.A new prognostic histopathologic classification of nasopharyngeal carcinoma.Chin J Cancer2016;35:41 PMCID:PMC4857443

[13] Shin DH,Suen HC.Pathologic staging of papillary carcinoma of the thyroid with airway invasion based on the anatomic manner of extension to the trachea: a clinicopathologic study based on 22 patients who underwent thyroidectomy and airway resection.Hum Pathol1993;24:866-70

[14] Dai Q,Zhang HK.Salvage endoscopic surgery for skull base osteoradionecrosis in nasopharyngeal carcinoma patients: a prospective, observational, single-arm clinical study.Rhinology2023;61:61-70

[15] Lee AW,Pan JJ.International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys2019;105:567-80

[16] Liu YP,Tang J.Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.Lancet Oncol2021;22:381-90

[17] Teo PM,Chan AT,King WW.How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?.Int J Radiat Oncol Biol Phys1998;40:897-913

[18] Yoshizaki T,Murono S,Furukawa M.Endoscopic nasopharyngectomy for patients with recurrent nasopharyngeal carcinoma at the primary site.Laryngoscope2005;115:1517-9

[19] Liu J,Wang D.Minimally invasive surgery for early-stage nasopharyngeal carcinoma.J Craniofac Surg2022;33:e834-7 PMCID:PMC9612703

[20] Liu YP,Zou X,Yang Q.Techniques of endoscopic nasopharyngectomy for localized stage I nasopharyngeal carcinoma.Head Neck2020;42:807-12

[21] Bozkurt G,Ferrari M.Salvage surgery in nasopharyngeal cancer: unraveling the efficacy of transnasal endoscopic nasopharyngectomy for advanced stage recurrent tumors.Oral Oncol2024;159:107048

[22] Castelnuovo P,Turri-Zanoni M.Endoscopic endonasal nasopharyngectomy in selected cancers.Otolaryngol Head Neck Surg2013;149:424-30

[23] Chen MY,Zhu YL.Use of a posterior pedicle nasal septum and floor mucoperiosteum flap to resurface the nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma.Head Neck2012;34:1383-8

[24] Wang ZQ,Liu YP.Endoscopic nasopharyngectomy combined with internal carotid artery pretreatment for recurrent nasopharyngeal carcinoma.Otolaryngol Head Neck Surg2022;166:490-7

[25] Hao SP,Chang KP,Chen CK.Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors.Acta Otolaryngol2008;128:473-81

[26] Chen MK.Minimally invasive endoscopic resection of sinonasal malignancies and skull base surgery.Acta Otolaryngol2006;126:981-6

[27] Geltzeiler M,Rimmer R.Endoscopic nasopharyngectomy combined with a nerve-sparing transpterygoid approach.Laryngoscope2020;130:2343-8

[28] Na’ara S,Billan S,Gil Z.Outcome of patients undergoing salvage surgery for recurrent nasopharyngeal carcinoma: a meta-analysis.Ann Surg Oncol2014;21:3056-62

[29] Wang EW,Gardner PA.ICAR: endoscopic skull-base surgery.Int Forum Allergy Rhinol2019;9:S145-365

[30] Liu J,Sun X.Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience.Int J Clin Oncol2017;22:834-42

[31] Castelnuovo P,Bignami M.Nasopharyngeal endoscopic resection in the management of selected malignancies: ten-year experience.Rhinology2010;48:84-9

[32] Chan JY,Wei WI.Morbidities after maxillary swing nasopharyngectomy for recurrent nasopharyngeal carcinoma.Head Neck2015;37:487-92

[33] Hao SP.Surgical management of recurrent nasopharyngeal carcinoma.Chang Gung Med J2010;33:361-9

[34] Chan JY.Critical appraisal of maxillary swing approach for nasopharyngeal carcinoma.Expert Opin Ther Targets2012;16 Suppl 1:S111-7

[35] Chan YW,Wei WI.Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.Cancer2012;118:3710-8

[36] Elliott Z,Swendseid B.Nasopharyngectomy without maxillary swing via a combined open lateral and endoscopic approach.Laryngoscope2023;133:105-8

[37] Morton RP,Mclean M.Transcervico-mandibulo-palatal approach for surgical salvage of recurrent nasopharyngeal cancer.Head Neck1996;18:352-8

[38] Fisch U.The infratemporal fossa approach for nasopharyngeal tumors.Laryngoscope1983;93:36-44

[39] Liu YP,You R.Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: selective or comprehensive neck dissection.Laryngoscope2019;129:387-95

[40] Chen H,Wang M.Retrospective study of selective neck dissection versus radical neck dissection as salvage therapy for patients with recurrent nasopharyngeal squamous cell carcinoma.J Craniomaxillofac Surg2014;42:1655-8

[41] Wang SY,Chen J,Guo L.Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma after primary radiotherapy: options of surgical methods and regions.World J Surg Oncol2016;14:89 PMCID:PMC4807573

[42] Zhang L,Wang Y,Wu Y.Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10-year experience.Ann Surg Oncol2011;18:233-8 PMCID:PMC3018243

[43] Li X,Yan J.Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection.Cancer Biol Med2020;17:227-36 PMCID:PMC7142849

[44] Chan JY,Wong ST.Surgical salvage for recurrent retropharyngeal lymph node metastasis in nasopharyngeal carcinoma.Head Neck2013;35:1726-31

[45] Ding X,Zou X.Transoral robotic retropharyngeal lymph node dissection in nasopharyngeal carcinoma with retropharyngeal lymph node recurrence.Laryngoscope2021;131:E1895-902

[46] Ozer E.Transoral robotic nasopharyngectomy: a novel approach for nasopharyngeal lesions.Laryngoscope2008;118:1613-6

[47] Tsang RK.Lateral palatal flap approach to the nasopharynx and parapharyngeal space for transoral robotic surgery: a cadaveric study.J Robot Surg2013;7:119-23 PMCID:PMC3657084

[48] Dallan I,Montevecchi F.Combined transoral transnasal robotic-assisted nasopharyngectomy: a cadaveric feasibility study.Eur Arch Otorhinolaryngol2012;269:235-9

[49] Gorphe P,Moya-Plana A.Cervical-transoral robotic nasopharyngectomy: a preclinical study.Head Neck2020;42:394-400

[50] Tsang RK,Holsinger FC.Long-term results of robotic-assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma.Head Neck2022;44:1940-7

[51] Tsang RK,Ho AC,Chan JY.Early results of robotic assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma.Head Neck2015;37:788-93

[52] Mai HQ,Deng JF.Endoscopic microwave coagulation therapy for early recurrent T1 nasopharyngeal carcinoma.Eur J Cancer2009;45:1107-10

[53] Liu TR,Qian CN.Primary salivary gland type carcinoma of the nasopharynx: therapeutic outcomes and prognostic factors.Head Neck2010;32:435-44

[54] Liu TR,Guo X.Adenoid cystic carcinoma of the nasopharynx: 27-year experience.Laryngoscope2008;118:1981-8

[55] You R,Hua YJ.Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma - a case-matched comparison.Radiother Oncol2015;115:399-406

[56] Thamboo A,Hwang PH.5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma.J Otolaryngol Head Neck Surg2021;50:12 PMCID:PMC7888158

[57] Wei WI.Salvage surgery for recurrent primary nasopharyngeal carcinoma.Crit Rev Oncol Hematol2000;33:91-8

[58] Chan JY.Impact of resection margin status on outcome after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.Head Neck2016;38 Suppl 1:E594-9

[59] Chan JY,Chow VL,Wei WI.Multivariate analysis of prognostic factors for salvage nasopharyngectomy via the maxillary swing approach.Head Neck2014;36:1013-7

[60] Lee AWM,Chan YH,Chan C.The battle against nasopharyngeal cancer.Radiother Oncol2012;104:272-8

[61] Peng G,Yang KY.A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.Radiother Oncol2012;104:286-93

[62] Sun Y,Chen NY.Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.Lancet Oncol2016;17:1509-20

[63] Ma BBY,Goh BC.Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the mayo clinic phase 2 consortium (NCI-9742).J Clin Oncol2018;36:1412-8 PMCID:PMC5941615

[64] Huang H,Deng X.Immunotherapy for nasopharyngeal carcinoma: current status and prospects (Review).Int J Oncol2023;63:97 PMCID:PMC10367053

[65] Bossi P,Chan A.Immunotherapy for nasopharyngeal carcinoma: the earlier the better.JAMA2023;330:1954-5